SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$RARI is an ERC-20 token that controls the RARI Foundation treasury and governs the Rarible protocol and RARI Chain. The token was issued in 2020 with a max. supply of 25 million $RARI.

Rarible

Rarible is generating significant social media buzz among traders who are highlighting its ultra-low circulating supply as a catalyst for potential volatility and upside. The community is actively debating its status as an undervalued project, with many users speculating on future exchange listings and comparing it to other market-moving NFT assets.

Welcome to the fabulous world of OKANE, where wealth meets wagging tails!   Inspired by the Japanese word for "money," OKANE is more than just a meme coin; it’s a celebration of all things cute, quirky, and oh-so-luxurious.  Meet our charming mascot, a pampered pup with a flair for the extravagant. With his sparkling collar and stylish shades, this adorable canine knows how to live the high life. Whether he’s lounging in a sun-soaked doggy mansion or attending exclusive puppy parties, our little tycoon embodies the spirit of prosperity and joy.

OKANE

OKANE is capturing market attention as traders highlight its steady price action and building momentum despite broader volatility. The community remains focused on the token's controlled movements and persistent buy pressure, often comparing its consolidation patterns to other emerging assets.

Veil Cash is a privacy application leveraging zk-SNARKs on Base L2, enabling verified depositors to achieve privacy and anonymity within a pool of trusted users.  Veil Cash is a non-custodial privacy protocol on Base L2. Veil Cash's goal will be enabling verified users to achieve privacy and anonymity from trusted pools.  Veil is a set of smart contracts that will allow users that are deemed as verified users to deposit into the protocol. Users can later withdraw their deposits from another address without creating a link between these two addresses.   Verified users are those who meet certain criteria based on both on-chain and off-chain data.

Veil-project

The Veil-project community is buzzing with enthusiasm as supporters highlight its focus on digital privacy, multi-algorithm mining, and staking capabilities. Traders are actively discussing the token's potential for future growth, drawing comparisons to established privacy-focused assets while emphasizing its role in securing financial sovereignty.

Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.

Eton Pharmaceuticals Inc

Eton Pharmaceuticals is currently trending due to its recent FDA approval for DESMODA, a milestone that community members view as a significant step in the company's evolution from a biotech hopeful to a revenue-generating commercial player. The community is actively discussing the stock's potential as an undervalued "hidden gem," citing strong recent financial performance, successful portfolio expansion, and an upcoming earnings report as key drivers for potential long-term growth.

EyePoint Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

EyePoint Inc.

EyePoint Pharmaceuticals Inc

EyePoint Pharmaceuticals is seeing heightened community discussion and investor focus as market participants eagerly await Phase 3 data readouts for its lead candidate, Duravyu, for wet AMD, which are anticipated mid-2026. The community is closely analyzing institutional accumulation, the company's competitive positioning against similar TKI-based therapies, and potential regulatory inflection points, while recent earnings volatility has fueled debate over the firm's cash runway and long-term valuation.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently a focal point for the community due to renewed institutional interest and a wave of activity surrounding its potential in real-world asset (RWA) tokenization and post-quantum security research. Investors are actively debating the long-term viability of the project, weighing concerns over its historical price performance against optimism that new governance developments and potential regulatory clarity will drive future utility.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is experiencing a surge in community interest driven by anticipation of upcoming cannabis-related catalysts and the approach of annual industry milestones. Supporters are actively highlighting the project's organic growth and long-term vision, positioning it as a culture-driven alternative to traditional cannabis stocks.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

General Motors is trending as investors react to a major strategic pivot, highlighted by a significant multibillion-dollar writedown tied to scaled-back electric vehicle plans and restructuring in China. While market sentiment remains mixed due to these charges and ongoing concerns regarding EV adoption, bullish investors are focused on the automaker's robust capital return programs, including recent dividend hikes and aggressive share buybacks.

EOG Resources, Inc. engages in the exploration, development, production and marketing of crude oil and natural gas. It operates through the United States, Trinidad, and Other International geographical segments. The Other International segment includes China and Canada operations. The company was founded in 1985 and is headquartered in Houston, TX.

EOG Resources, Inc.

EOG Resources is trending as investors weigh recent analyst target increases against a broader energy sector landscape shaped by robust production efficiency and global supply volatility. The community remains focused on the company's strong operational fundamentals and its strategy of returning capital to shareholders through dividends and opportunistic repurchases.

Pump.fun

Pump.fun is trending as investors weigh its role in memecoin volatility against its high-volume performance on the Solana network, with communities actively debating the balance between gambling risks and the potential for organic viral growth. Discussion remains polarized, centered on intense community-led projects like $PMV and $WAGMI, which traders are using to anchor conversations around long-term conviction and culture-driven market movement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tema Etfs LLC Decreases Position in Revolution Medicines, Inc. $RVMD

Tema Etfs LLC trimmed its holdings in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 20.7% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange...

Revolution Medicines, Inc. (NASDAQ:RVMD) Given Average Rating of "Buy" by Analysts

Shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) have been given a consensus rating of "Buy" by the twenty-one ratings firms that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, fifteen have given...

Revolution Medicines (RVMD) Down 8.8% Since Last Earnings Report: Can It Rebound?

Revolution Medicines (RVMD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Revolution Medicines Sees Unusually High Options Volume (NASDAQ:RVMD)

Revolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) was the target of unusually large options trading activity on Friday. Stock investors bought 12,797 put options on the company. This represents an increase of 131% compared to the average daily volume of 5,546 put options...

Insider Selling: Revolution Medicines (NASDAQ:RVMD) Insider Sells 2,010 Shares of Stock

Revolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) insider Xiaolin Wang sold 2,010 shares of the stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $99.48, for a total value of $199,954.80. Following the sale, the insider directly owned...

Revolution Medicines (NASDAQ:RVMD) Insider Sells 2,073 Shares

Revolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) insider Lin Wei sold 2,073 shares of the firm's stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $99.48, for a total value of $206,222.04. Following the completion of the transaction, the insider...

Revolution Medicines (NASDAQ:RVMD) Insider Sells $427,962.96 in Stock

Revolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) insider Stephen Michael Kelsey sold 4,302 shares of the stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $99.48, for a total value of $427,962.96. Following the transaction, the insider...

Insider Selling: Revolution Medicines (NASDAQ:RVMD) COO Sells 4,583 Shares of Stock

Revolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) COO Margaret Horn sold 4,583 shares of the firm's stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $99.48, for a total transaction of $455,916.84. Following the completion of the transaction, the...

Insider Selling: Revolution Medicines (NASDAQ:RVMD) CFO Sells 2,753 Shares of Stock

Revolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) CFO Jack Anders sold 2,753 shares of the stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $99.48, for a total value of $273,868.44. Following the completion of the transaction, the chief...

Revolution Medicines (NASDAQ:RVMD) Insider Mark Goldsmith Sells 12,871 Shares

Revolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) insider Mark Goldsmith sold 12,871 shares of the firm's stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $99.48, for a total transaction of $1,280,407.08. Following the completion of...

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

Current Price	$99.12
Prev Close	$98.64
Open	$96.47
Dividend Yield	0.00%
50-Day Moving Average	$99.12
Beta	1.10
Avg. Volume	1.93M
PE Ratio	-16.75

52-Week High	$124.49
52-Week Low	$29.17
Market Capitalization	$19.64B
EPS (Annual)	-$5.95
Price to Book	11.97
Revenue Per Employee	$0.00

RVMD
Revolution Medicines Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RVMD News

RVMDRevolution Medicines Inc